Optimization of the Management of Non-Traumatic Intracerebral Hemorrhage (OPT-ICH)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2027-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intracerebral non-traumatic intraparenchymal hemorrhages (ICH) account for 15 to 20% of strokes. One third of the patients dies within the month following ICH, and survivors often experience residual disability with a high risk of recurrent ICH, other serious vascular events, and neurological complications such as epilepsy and dementia. Encouraging but preliminary data suggest a favorable trend in terms of survival rates in recent years. This is partly due to improved management of patients with ICH, which must be early (the concept of "time is brain") and carried out by expert personnel (medical and paramedical) in specialized units.

The main objectives of the study are:

* To evaluate the management of patients with ICH in the acute phase within the University Hospital of Tours by analyzing the procedures adopted in the various relevant departments (neurovascular units, neurosurgery, medical or neurosurgical intensive care, geriatrics);
* To evaluate whether the systematic implementation of a dedicated protocol (see \*) for the management of patients with ICH is associated with a reduction in mortality and disability in the short and long term.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality Improvement Initiative for Enhancing Early Mobilization in Intracerebral Hemorrhage Patients

NCT06811350

Primary Intracerebral Hemorrhage Early Mobilization

ACTIVE_NOT_RECRUITING

Neurological Outcomes of Primary Intracerebral Haemorrhage

NCT03995940

Intracranial Hemorrhage, Hypertensive

UNKNOWN

Longitudinal Cohort Study on ICH Care

NCT03183167

Spontaneous Intracerebral Hemorrhage

COMPLETED

International Care Bundle Evaluation in Cerebral Hemorrhage Research

NCT06429332

Intracerebral Hemorrhage Intracerebral Haemorrhage Intraventricular Hemorrhage +2 more

RECRUITING PHASE4

A Cohort Study of Patients With Intracranial Hemorrhage

NCT05760950

Intracerebral Hemorrhage

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project consists of 2 parts:

* Retrospective, multicentric, observational study. Inclusion of all patients presenting with ICH admitted urgently to the University Hospital of Tours between 2018-2021.
* Prospective, multicentric, observational study. Inclusion of all patients presenting with ICH admitted urgently to the University Hospital of Tours, Angers and Poitiers.

Each patient will benefit from management according to a protocol which will include:

* Emergency MRI with contrast injection (contrast-enhanced brain CT scan if contraindicated);
* Admission to the Neurovascular Unit unless hemodynamically unstable or intubated;
* First intravenous antihypertensive injection with a goal \< 1 hour from arrival at the hospital;
* Anticoagulation reversal with a goal \< 1 hour from arrival at the hospital;
* Standard laboratory tests + coagulation study ;
* Neurosurgical consultation upon arrival at the department;
* Follow-up MRI at 24-48 hours or earlier if clinical worsening;
* Diagnostic work-up for the evaluation of hypertension-related end organ damage (Transthoracic echocardiogram, retinography , proteinuria);
* Contrast-enhanced follow-up MRI at 3-6 months;
* Neurological evaluation at 6 months and 2 years;
* When applicable a neuropsychological evaluation at 6M and 2 Y;

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracerebral Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged over 18 years
* emergency admission to the University Hospital of Tours
* having an ICH on imaging performed upon admission (CT scan or MRI) at the University Hospital of Tours